30 Lawsuits Against the Makers of a Low Testosterone Drug Have Been Consolidated

The Long Island law firm of Rudolph F. X. Migliore, P. C. has announced the United States District Court for the Northern District of Illinois has consolidated 30 cases that involve the pharmaceutical company AbbVie, Inc., for their medical product known as “AndroGel.” Commack, NY (PRWEB) March 26, 2014 AndroGel is a part of a drug group called testosterone replacement therapy drugs. The FDA (Testosterone Products: Drug Safety Communication - FDA Investigating Risk of Cardiovascular Events 01/31/2014) has recently begun monitoring the correlation between low testosterone therapy and heart
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations